| buprenorphine transdermal / Generic mfg. |
2007-006117-16: A prospective, randomised, phase IV, open label clinical trial to study the therapeutic use of buprenorphine 20 mg (BuTrans 20µg/h) matrix transdermal patch in the management of post tonsillectomy pain in adults |
|
|
| Ongoing | 4 | 300 | Europe | BuTrans® 20 μg/h transdermal patch, Solpadol Effervescent Tablets, n/a, BuTrans® 20 μg/h Transdermal Patch, Solpadol Effervescent Tablets, BuTrans® 20 μg/h Transdermal Patch, Solpadol Effervescent Tablets | Betsi Cadwaladr University Health Board | post-tonsillectomy pain | | | | |
2007-002357-23: An open label, randomized 2 part crossover study to investigate the effect of buprenorphine transdermal delivery system (BTDS) compared with co-codamol on physical activity in subjects aged 60 years or over with knee pain secondary to osteoarthritis. |
|
|
| Ongoing | 4 | 20 | Europe | BuTrans 5 μg/h transdermal patch, BuTrans 10 μg/h transdermal patch, BuTrans 20 μg/h transdermal patch, Paracetamol Tablets BP 500mg, Co-codamol tablets BP 8/500mg, Copaz caplet, Co-codamol 30/500 mg Tablets BP, BuTrans 5 μg/h transdermal patch, BuTrans 10 μg/h transdermal patch, BuTrans 20 μg/h transdermal patch, Paracetamol Tablets BP 500mg, Co-codamol tablets BP 8/500mg, Copaz caplet, Co-codamol 30/500 mg Tablets BP | Newcastle Upon Tyne NHS Foundation Trust | Osteoarthritis of the knee | | | | |
ChiCTR-OPC-17011315: Comparison of different analgesic strategies in elderly patients with spinal chronic muscle skeletal pain |
|
|
| Not yet recruiting | 4 | 330 | | Buprenorphine Transdermal patch ;Tramadol Hydrochloride Sustained Release Tablets ;NSAIDs | Peking Union Medical College Hospital; Peking Union Medical College Hospital, raise independently | Spinal chronic muscle skeletal pain | | | | |
ChiCTR-IPR-17012931: Perioperative analgesia with a buprenorphine transdermal patch for foot and ankle surgery: A prospective, randomized, controlled study |
|
|
| Not yet recruiting | 4 | 120 | | The patients in test group administered BTDS 2 days before the operation until 5 days after the operation ;The patients in control group administered postoperative analgesia with PCIA immediately, and last two days. | Xiangya Hospital, Central South University; Xiangya Hospital, Central South University, Mundipharma Limited, Mundipharma GmbH & Co. KG | Foot and ankle disease, like hallux valgus | | | | |
ChiCTR1800015249: Perioperative analgesia with a buprenorphine transdermal patch for foot and ankle surgery: A randomized controlled trail |
|
|
| Completed | 4 | 90 | | flurbiprofen axetil intravenous injection; oral celecoxib ;BTDS | Xiangya Hospital, Central South University; Xiangya Hospital, Central South University, Mundipharma Limited, Mundipharma GmbH & Co. KG | Foot and ankle disease, especially hallux valgus | | | | |
ChiCTR-OPC-17013583: A prospective, multicenter, observational study for buprenorphine transdermal patch (Norspan) in the treatment of osteoarthrosis patients with chronic pain |
|
|
| Not yet recruiting | 4 | 1000 | | buprenorphine transdermal patch 5mg/7days for 4 weeks | West China Hospital, Sichuan University; Mundipharma (China) Pharmaceutical CO.LTD, Sponsored by Mundipharma(China)Pharmaceutical CO.LTD | Osteoarthrosis patients with chronic pain | | | | |
ChiCTR1800014977: A retrospective study on clinical efficacy and safety of adjunctive therapy for knee osteoarthritis with the treatment of buprenorphine transdermal patches, diprospan and celebrex |
|
|
| Not yet recruiting | 4 | 400 | | Physicotherapeutics add Celebrex ;Physicotherapeutics + Diprospan ;Physicotherapeutics + Buprenorphine Transdermal Patches ;Physicotherapeutics | Hu'nan Province People's hospital; Hunan Province People's hospital, Horizontal scientific research project | knee osteoarthritis | | | | |
ChiCTR2400090209: Bioequivalence and adhesion tests of Buprenorphine Transdermal Patches in humans |
|
|
| Not yet recruiting | 4 | 40 | | Phase 1 Buprenorphine Transdermal Patches（R）；Phase 2 Buprenorphine Transdermal Patches（T）; Phase 1 Buprenorphine Transdermal Patches（T）；Phase 2 Buprenorphine Transdermal Patches（R） | Second Affiliated Hospital of Guangzhou Medical University; Second Affiliated Hospital of Guangzhou Medical University, Yichang Humanwell Pharmaceutical Co.,Ltd. | Chronic pain not controlled by non-opioid analgesics | | | | |
NCT06742554: Comparative Efficacy of Buprenorphine Transdermal Patch Versus Tramadol in Postoperative Analgesia for Shoulder Arthroscopy |
|
|
| Active, not recruiting | 4 | 70 | RoW | Buprenorphine transdermal patch, Tramadol | medina medical center | Postoperative Pain, Shoulder Pain, Opioid Analgesia, Tramadol, Buprenorphine, Arthroscopy, Interscalene Brachial Plexus Block, Analgesic | 04/25 | 04/25 | | |
ACTRN12608000242325: A Multicentre, Randomised, Double-Blind, Parallel Group Comparison Of The Efficacy And Safety Of Transdermal Buprenorphine (Norspan'registered trade mark' BTDS) And Placebo In Patients With Postherpetic Neuralgia. |
|
|
| Active, not recruiting | 3/4 | 124 | | | Mundipharma Pty Limited, Mundipharma Pty Limited | Post Herpetic Neuralgia | | | | |
ACTRN12609000647235: A Multicentre, Randomised, Double-Blind, Parallel Group Comparison Of The Efficacy And Safety Of Transdermal Buprenorphine (Norspan'registered trade mark' Buprenorphine transdermal system [BTDS]) And Placebo In Patients With Diabetic Peripheral Neuropathic Pain. |
|
|
| Active, not recruiting | 3/4 | 186 | | | Mundipharma Pty Limited, Mundipharma Pty Limited | Diabetic Peripheral Neuropathic Pain | | | | |
BUP12-AP-401, ChiCTR-TCS-14004252: A multicenter study for the evaluation of efficacy & safety of buprenorphine transdermal patch (Norspan or Sovenor transdermal patch) in patients with non-malignant pain of moderate to severe intensity due to osteoarthritis, rheumatoid arthritis, lower back pain and joint/muscle pain, when an opioid |
|
|
| Not yet recruiting | 1 | 15 | | Norspan 5mg patch (1 patch per week), and the dose can be titrated up to maximum 40mg patch in the titration period (maximun 42 days). Patient will then be using the optimum dosage for 11 weeks, and follow-up for another 2 weeks after treatment period, maximum 19 weeks | The Chinese University of Hong Kong; None, Mundipharma (Hong Kong) Limited | osteoarthritis, rheumatoid arthritis, lower back pain, joint/muscle pain | | | | |
| Completed | 1 | 45 | | BUP TDS 20mg for 3 days ;BUP TDS 40 mg for 3 days ;BUP TDS 40 mg for 4 days | Affiliated Hospital of Liaoning University of Traditional Chinese Medicine; Mundipharma (China) Pharmaceutical Co. Ltd., sponsor | Chronic Pain | | | | |
NCT05852093: Clinical Study on the Effect of Tizanidine on the Function and Pain of Patients After Shoulder Arthroscopy |
|
|
| Not yet recruiting | 1 | 100 | NA | Celecoxib+Buprenorphine Transdermal Patch, Celecoxib+Buprenorphine Transdermal Patch+Tizanidine | Second Affiliated Hospital, School of Medicine, Zhejiang University | Rotator Cuff Tears | 06/26 | 06/27 | | |
ChiCTR1800016379: A trial of the effects of chronic pain related factors and postoperative analgesic effect during perioperative period in Department of thoracic surgery |
|
|
| Recruiting | N/A | 150 | | PCIA+ Flurbiprofen Axetil Injection + buprenorphine transdermal patch ;PCIA+ Flurbiprofen Axetil Injection ;Flurbiprofen Axetil Injection + buprenorphine transdermal patch | Affiliated Hospital of Qingdao University; Affiliated Hospital of Qiingdao University, N/A | lung cancer | | | | |
ChiCTR1900027892: Clinical study for the effect of preoperative analgesia on total knee replacement on postoperative rehabilitation |
|
|
| Completed | N/A | 90 | | Buprenorphine transdermal patch 2.5mg applied to deltoid muscle 12h before surgery ;Celecoxib 200mg orally 12h before surgery ;No advanced analgesia | Lanzhou University Second Hospital; Lanzhou University Second Hospital, self-financing | Knee osteoarthritis | | | | |
ChiCTR2300069182: Buprenorphine transdermal patches are used for postoperative analgesia in rotator cuff injury repair safety and efficacy: a prospective randomized control study |
|
|
| Recruiting | N/A | 64 | | Analgesia is relieved by buprenorphine transdermal patches after surgery for rotator cuff injuries ;Acromikates are followed by a nonsteroidal anti-inflammatory drug combined with tramadol analgesia | Drum Tower Hospital Affiliated to Nanjing University School of Medicine; Drum Tower Hospital Affiliated to Nanjing University School of Medicine, No | Rotator cuff injury | | | | |
NCT05883358: Kratom Use Disorder Management Using Clonidine and/or Buprenorphine |
|
|
| Recruiting | N/A | 50 | Canada | Clonidine, Buprenorphine, Clonidine, Butrans | Salem Anaesthesia Pain Clinic | Withdrawal Syndrome | 12/24 | 12/24 | | |
NCT03977012: Neuroimaging Study on the Effect of Transdermal Buprenorphine in Complex Regional Pain Syndrome Patients |
|
|
| Recruiting | N/A | 20 | RoW | Buprenorphine, norspan patch | Seoul National University Hospital | Complex Regional Pain Syndromes | 04/24 | 05/24 | | |
ChiCTR2100047449: Analysis of the effect of buprenorphine transdermal patch on patients with moderate to severe chronic pain |
|
|
| Recruiting | N/A | 300 | | None | The Second Affiliated Hospital of Zhejiang University; The Second Affiliated Hospital of Zhejiang University, None | chronic pain | | | | |
